Drug Trial Radar · NCT05650229
Efficacy of KL1333 in Adult Patients With Primary Mitochondrial Disease
Last checked: Nov 19, 2026Latest source record: Jun 26, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
180
Planned (sponsor's estimate)
Start
Dec 13, 2022
Primary completion
Oct 2027
Study completion Nov 2027
Sponsor
- Lead sponsor
- Pharming Technologies B.V.Industry
- Sponsor type
- Industry
- First posted
- Dec 14, 2022
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The primary objective of the FALCON study is to evaluate the efficacy of KL1333 on selected disease manifestations of primary mitochondrial disease (PMD) following 48 weeks of treatment. This objective involves evaluating the efficacy of KL1333 versus placebo on fatigue symptoms and impacts on daily living as well as on functional lower extremity strength and endurance. Additionally, the study evaluates the safety and tolerability of KL1333.
Conditions
- Primary Mitochondrial Disease
Interventions
KL1333Drug
Twice daily
PlaceboDrug
Twice daily
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in-patient-reported fatigue symptoms and impacts on daily living measured by Patient-Reported Outcomes Measurement Information System (PROMIS®) Fatigue PMD Short FormTime frame: Baseline and 48 Weeks
- Change in 30 Second Site-to-Stand Test.Time frame: Baseline and 48 Weeks
Locations
55 sites in 11 countries. Site status is shown where the registry gives one.
University of California, Irvine - ALS & Neuromuscular Center
Orange, California · Recruiting
The Regents of the University of California - San Diego
San Diego, California · Recruiting
UCSF Movement Disorders Clinic
San Francisco, California · Not yet recruiting
Children's Hospital Colorado - Center for Cancer and Blood Disorders (CCBD) - Anschutz Medical Campus Location
Aurora, Colorado · Recruiting
Yale University School of Medicine
New Haven, Connecticut · Not yet recruiting
Novel Clinical Research Center, LLC
Miami, Florida · Recruiting
Rare Disease Research, LLC
Atlanta, Georgia · Recruiting
IU Health University Hospital
Indianapolis, Indiana · Not yet recruiting
Johns Hopkins University School of Medicine
Baltimore, Maryland · Not yet recruiting
Mayo Clinic
Rochester, Minnesota · Recruiting
Washington University School of Medicine - Center for Advanced Medicine (CAM) - Neuroscience Center
St Louis, Missouri · Not yet recruiting
Tekton Marlboro Neurology
Marlboro, New Jersey · Recruiting
Columbia University Irving Medical Center
New York, New York · Not yet recruiting
Icahn School of Medicine at Mount Sinai
New York, New York · Not yet recruiting
Akron Children's Hospital
Akron, Ohio · Recruiting
The Children's Hospital of Philadelphia
Philadelphia, Pennsylvania · Not yet recruiting
UPMC Children's Hospital of Pittsburgh
Pittsburgh, Pennsylvania · Recruiting
Neurology and Neuromuscular Care Center-Neurology Rare Disease Center
Flower Mound, Texas · Not yet recruiting
Baylor College of Medicine (BCM)
Houston, Texas · Recruiting
The University of Texas Health Science Center at Houston
Houston, Texas · Recruiting
Neuroscience Research Australia
Randwick, New South Wales, Australia · Not yet recruiting
Royal North Shore Hospital
Saint Leonards, New South Wales, Australia · Not yet recruiting
Royal Melbourne Hospital
Parkville, Victoria, Australia · Not yet recruiting
Perron Institute
Nedlands, Western Australia, Australia · Not yet recruiting
Hopital Universitaire de Bruxelles (H.U.B)/ Academisch Ziekenhuis Brussel
Brussels, Belgium · Recruiting
Universitair Ziekenhuis Gent
Ghent, Belgium · Recruiting
Universitair Ziekenhuis Leuven Gasthuisberg Campus
Leuven, Belgium · Recruiting
Charles University and General University Hospital
Prague, Czechia · Not yet recruiting
Copenhagen Neuromuscular Center, Rigshospitalet
Copenhagen, Denmark · Recruiting
Centre Hospitalier Universitaire d'Angers
Angers, France · Recruiting
Centre Hospitalier Universitaire (CHU) de Bordeaux - Groupe Hospitalier Pellegrin
Bordeaux, France · Recruiting
Hopital Roger Salengro, CHRU de Lille
Lille, France · Recruiting
Centre Hospitalier Universitaire de Nantes
Nantes, France · Not yet recruiting
Centre Hospitalier Universitaire de Nice, Hopital Pasteur 2
Nice, France · Recruiting
CHU de NICE - Hôpital Archet 2
Nice, France · Recruiting
Hopital Universitaire Necker Enfants Malades
Paris, France · Not yet recruiting
Groupe Hospitalier Pitie-Salpetriere
Paris, France · Recruiting
Hopitaux Universitaires de Strasbourg
Strasbourg, France · Recruiting
Charite - Universitaetsmedizin Berlin
Berlin, Germany · Recruiting
Universitaetsklinikum Halle
Halle, Germany · Recruiting
Showing 40 of 55 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.